Christine Cassiano | CCO |
David Chang | President and CEO |
Rafael Amado | EVP, Research & Development and CMO |
Eric Schmidt | CFO |
Andrea Tan | Goldman Sachs |
Michael Yee | Jefferies |
Tyler Van Buren | Cowen |
Asthika Goonewardene | Truist |
Raju Prasad | William Blair |
Reni Benjamin | JMP Securities |
Mark Breidenbach | Oppenheimer |
John Newman | Canaccord Genuity |
Michael Schmidt | Guggenheim Partners |
Luca Issi | RBC Capital Markets |
Jason Gerberry | Bank of America |
Kalpit Patel | B. Riley |
David Dai | SMBC |
Jack Allen | Baird |
Brian Cheng | JPMorgan |
Robert Burns | H.C. Wainwright |
Dane Leone | Raymond James |
Ben Burnett | Stifel |
Hello, and thank you for standing by, and welcome to Allogene Therapeutics Third Quarter of 2022 Conference Call. [Operator Instructions] Please be aware that today's conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.